Justin Xavier Moore1, Tomi Akinyemiju2, Alfred Bartolucci3, Henry E Wang4, John Waterbor5, Russell Griffin5. 1. Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, United States; Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, United States; Division of Public Health Sciences, Department of Surgery, Washington University in Saint Louis School of Medicine, St Louis, MO, United States. Electronic address: jxmoore@wustl.edu. 2. Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, United States; Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, United States; Department of Epidemiology, University of Kentucky, Lexington, KY, United States. 3. Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, United States. 4. Department of Emergency Medicine, University of Texas Health Science Center at Houston, Houston, TX, United States. 5. Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, United States.
Abstract
BACKGROUND: Hospitalized cancer patients are nearly 10 times more likely to develop sepsis when compared to patients with no cancer history. We compared the risk of sepsis between cancer survivors and no cancer history participants, and examined whether race was an effect modifier. METHODS: We performed a prospective analysis of data from the REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort. We categorized participants as "cancer survivors" or "no cancer history" derived from self-reported responses of being diagnosed with any cancer, excluding non-melanoma skin cancer. We defined sepsis as hospitalization for a serious infection with ≥2 systemic inflammatory response syndrome criteria. We performed Cox proportional hazard models to examine the risk of sepsis after cancer (adjusted for sociodemographics, health behaviors, and comorbidities), and stratified by race. RESULTS: Among 29,693 eligible participants, 2959 (9.97%) were cancer survivors, and 26,734 (90.03%) were no cancer history participants. Among 1393 sepsis events, the risk of sepsis was higher for cancer survivors (adjusted HR: 2.61, 95% CI: 2.29-2.98) when compared to no cancer history participants. Risk of sepsis after cancer survivorship was similar for Black and White participants (p value for race and cancer interaction = 0.63). CONCLUSION: In this prospective cohort of community-dwelling adults we observed that cancer survivors had more than a 2.5-fold increased risk of sepsis. Public health efforts should attempt to mitigate sepsis risk by awareness and appropriate treatment (e.g., antibiotic administration) to cancer survivors with suspected infection regardless of the number of years since cancer remission.
BACKGROUND: Hospitalized cancer patients are nearly 10 times more likely to develop sepsis when compared to patients with no cancer history. We compared the risk of sepsis between cancer survivors and no cancer history participants, and examined whether race was an effect modifier. METHODS: We performed a prospective analysis of data from the REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort. We categorized participants as "cancer survivors" or "no cancer history" derived from self-reported responses of being diagnosed with any cancer, excluding non-melanoma skin cancer. We defined sepsis as hospitalization for a serious infection with ≥2 systemic inflammatory response syndrome criteria. We performed Cox proportional hazard models to examine the risk of sepsis after cancer (adjusted for sociodemographics, health behaviors, and comorbidities), and stratified by race. RESULTS: Among 29,693 eligible participants, 2959 (9.97%) were cancer survivors, and 26,734 (90.03%) were no cancer history participants. Among 1393 sepsis events, the risk of sepsis was higher for cancer survivors (adjusted HR: 2.61, 95% CI: 2.29-2.98) when compared to no cancer history participants. Risk of sepsis after cancer survivorship was similar for Black and White participants (p value for race and cancer interaction = 0.63). CONCLUSION: In this prospective cohort of community-dwelling adults we observed that cancer survivors had more than a 2.5-fold increased risk of sepsis. Public health efforts should attempt to mitigate sepsis risk by awareness and appropriate treatment (e.g., antibiotic administration) to cancer survivors with suspected infection regardless of the number of years since cancer remission.
Authors: Rachel A Freedman; Katherine S Virgo; Yulei He; Alexandre L Pavluck; Eric P Winer; Elizabeth M Ward; Nancy L Keating Journal: Cancer Date: 2010-10-11 Impact factor: 6.860
Authors: Vanessa B Sheppard; Bridget A Oppong; Regina Hampton; Felicia Snead; Sara Horton; Fikru Hirpa; Echo J Brathwaite; Kepher Makambi; S Onyewu; Marc Boisvert; Shawna Willey Journal: Ann Surg Oncol Date: 2015-02-05 Impact factor: 5.344
Authors: Karin Gwyn; Melissa L Bondy; Deborah S Cohen; Mary Jo Lund; Jonathan M Liff; Elaine W Flagg; Louise A Brinton; J William Eley; Ralph J Coates Journal: Cancer Date: 2004-04-15 Impact factor: 6.860
Authors: Jesse D Sammon; Dane E Klett; Akshay Sood; Kola Olugbade; Marianne Schmid; Simon P Kim; Mani Menon; Quoc-Dien Trinh Journal: J Surg Res Date: 2014-07-24 Impact factor: 2.192
Authors: Tomi F Akinyemiju; Amr S Soliman; Glenn Copeland; Mousumi Banerjee; Kendra Schwartz; Sofia D Merajver Journal: PLoS One Date: 2013-04-29 Impact factor: 3.240
Authors: Justin Xavier Moore; John P Donnelly; Russell Griffin; Monika M Safford; George Howard; John Baddley; Henry E Wang Journal: Crit Care Date: 2015-07-10 Impact factor: 9.097
Authors: Aimee M Foord; Kara L Cushing-Haugen; Michael J Boeckh; Paul A Carpenter; Mary E D Flowers; Stephanie J Lee; Wendy M Leisenring; Beth A Mueller; Joshua A Hill; Eric J Chow Journal: Blood Adv Date: 2020-04-14